MSS51: A Drug Target / Disease Biomarker (G118490)

Target Name: MSS51

NCBI ID: G118490

MSS51

MSS51: A Drug Target / Disease Biomarker

MSS51, also known as melanoma-associated protein 51, is a protein that is expressed in high levels in melanoma cells. It is a potential drug target for cancer treatment, due to its ability to trigger an immune response in cancer cells, which can lead to the destruction of cancer cells.

MSS51 is a transmembrane protein that is expressed in various tissues throughout the body, including the skin, hair, and eyes. It is one of a family of proteins called the melanoma-associated protein (MAP) family, which includes several other proteins that are involved in the development and progression of melanoma.

MSS51 is involved in several cellular processes that are important for cancer development. It is a potent activator of the T-cell receptor, which is a critical signaling pathway that helps coordinate the immune response to cancer cells. MSS51 has been shown to stimulate the production of T-cells in cancer cells, which can help to recognize and destroy cancer cells.

In addition to its role in immune regulation, MSS51 is also involved in the development of cancer by promoting the formation of blood vessels in cancer cells. Blood vessels are essential for the delivery of oxygen and nutrients to cancer cells, which allows them to grow and multiply rapidly. By promoting the formation of blood vessels, MSS51 may contribute to the development of new blood vessels that can feed the growth and expansion of cancer cells.

MSS51 is also a potential biomarker for cancer diagnosis and treatment. Its expression has been detected in a variety of cancer types, including melanoma, lung cancer, and breast cancer. Therefore, it may be a useful target for cancer diagnostics and therapies that specifically target cancer cells that express high levels of MSS51.

In conclusion, MSS51 is a protein that is expressed in high levels in cancer cells and has been shown to be involved in several cellular processes that are important for cancer development. Its potential as a drug target makes it an attractive target for cancer treatment, and its potential as a biomarker for cancer diagnosis makes it an important tool for cancer research. Further studies are needed to fully understand the role of MSS51 in cancer biology and to develop effective therapies that target cancer cells that express high levels of this protein.

Protein Name: MSS51 Mitochondrial Translational Activator

The "MSS51 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MSS51 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets